In Mecp2 null (Mecp2−/y) mice, severe neurological phenotypic features, including hypoactivity, seizures, motor dysfunction, ataxia, and early death (8–10 weeks), were found [16, 17]. Here, MECP2 is linked to cerebellar ataxia.